產品中心

產品型號:S0B2169
更新時間:2025-10-09
廠商性質:生產廠家
訪問量:60
服務熱線15855403091
相關文章
B7 homolog 3 protein (B7-H3, also known as CD276), a newly identified immunoregulatory protein member of the B7 family, is an attractive and promising target for cancer immunotherapy because it is overexpressed in tumor tissues while showing limited expression in normal tissues and participating in tumor microenvironment (TME) shaping and development. Thus far, numerous B7-H3-based immunotherapy strategies have demonstrated potent antitumor activity and acceptable safety profiles in preclinical models [PMID: 34349762].